Parametrica Management’s Bausch Health BHC Stock Holding History

Parametrica Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,139	Closed	-$415K	–	187
2022 Q1	$415K	Buy	+18,139	New	+$443K	0.31%	71

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Parametrica Management's BHC Position: Q2 2022 in Review

Parametrica Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 18,139 shares — an estimated $415K sold.

Parametrica Management first reported a position in BHC in Q1 2022 and held it in 1 quarter. The position peaked at $415K in Q1 2022. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Parametrica Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Parametrica Management sold 18,139 Bausch Health shares in Q2 2022, an estimated $415K.
Parametrica Management first reported a position in Bausch Health in Q1 2022 and held it in 1 quarter.
Parametrica Management's Bausch Health position peaked at $415K in Q1 2022.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Parametrica Management's 13F filing for Q2 2022, filed 22 Jul 2022.